EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for RBSH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 -0.0008
March 31, 2023 -0.0132
December 31, 2022 0.0198
September 30, 2022 0.0018
June 30, 2022 -0.0425
March 31, 2022 -0.0196
December 31, 2021 -0.0395
September 30, 2021 -0.4185
June 30, 2021 0.4462
March 31, 2021 -3.642
December 31, 2020 -2.652
September 30, 2020 -0.0188
June 30, 2020 -17.62
March 31, 2020 -26.73
December 31, 2019 -129.42
September 30, 2019 3947.06
June 30, 2019 -314.44
March 31, 2019 -29.25
December 31, 2018 1404.00
September 30, 2018 -8271.56
June 30, 2018 -97.88
March 31, 2018 -1230.19
December 31, 2017 -28199.81
September 30, 2017 -54208.13
June 30, 2017 -29046.94
Date Value
March 31, 2017 -84231.56
December 31, 2016 -54562.50
September 30, 2016 -49494.38
June 30, 2016 -16875.00
March 31, 2016 -16875.00
December 31, 2015 -45950.62
September 30, 2015 -67500.00
June 30, 2015 -84375.00
March 31, 2015 -101250.0
December 31, 2014 -84375.00
September 30, 2014 -84375.00
June 30, 2014 -101250.0
March 31, 2014 -118125.0
December 31, 2013 -118125.0
September 30, 2013 -67500.00
June 30, 2013 -67500.00
March 31, 2013 -101250.0
December 31, 2012 -100321.9
September 30, 2012 -135000.0
June 30, 2012 -67500.00
March 31, 2012 -236250.0
December 31, 2011 -151875.0
September 30, 2011 -135000.0
June 30, 2011 -135000.0
March 31, 2011 -33750.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422